[go: up one dir, main page]

AP2514A - HIV reverse transcriptase inhibitors - Google Patents

HIV reverse transcriptase inhibitors

Info

Publication number
AP2514A
AP2514A AP2009004759A AP2009004759A AP2514A AP 2514 A AP2514 A AP 2514A AP 2009004759 A AP2009004759 A AP 2009004759A AP 2009004759 A AP2009004759 A AP 2009004759A AP 2514 A AP2514 A AP 2514A
Authority
AP
ARIPO
Prior art keywords
reverse transcriptase
transcriptase inhibitors
hiv reverse
hiv
inhibitors
Prior art date
Application number
AP2009004759A
Other languages
English (en)
Other versions
AP2009004759A0 (en
Inventor
Hongyan Guo
Choung U Kim
Young Lee Iii
Original Assignee
Korea Res Inst Chem Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Res Inst Chem Tech filed Critical Korea Res Inst Chem Tech
Publication of AP2009004759A0 publication Critical patent/AP2009004759A0/xx
Application granted granted Critical
Publication of AP2514A publication Critical patent/AP2514A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2009004759A 2006-07-24 2007-07-24 HIV reverse transcriptase inhibitors AP2514A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83280606P 2006-07-24 2006-07-24
PCT/US2007/016703 WO2008016522A2 (en) 2006-07-24 2007-07-24 Hiv reverse transcriptase inhibitors

Publications (2)

Publication Number Publication Date
AP2009004759A0 AP2009004759A0 (en) 2009-02-28
AP2514A true AP2514A (en) 2012-11-23

Family

ID=38997642

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2009004759A AP2514A (en) 2006-07-24 2007-07-24 HIV reverse transcriptase inhibitors

Country Status (18)

Country Link
US (2) US20100034827A1 (es)
EP (1) EP2044037A2 (es)
JP (1) JP2009544710A (es)
KR (2) KR20110089463A (es)
CN (1) CN101495461A (es)
AP (1) AP2514A (es)
AU (1) AU2007281604A1 (es)
BR (1) BRPI0714880A2 (es)
CA (1) CA2658479A1 (es)
EA (1) EA200900213A1 (es)
HR (1) HRP20090114A2 (es)
IL (1) IL196675A0 (es)
MX (1) MX2009000871A (es)
NO (1) NO20090835L (es)
NZ (1) NZ573793A (es)
SG (1) SG174016A1 (es)
UA (1) UA95955C2 (es)
WO (1) WO2008016522A2 (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG174016A1 (en) * 2006-07-24 2011-09-29 Korea Res Inst Chem Tech Hiv reverse transcriptase inhibitors
US8354421B2 (en) * 2007-06-29 2013-01-15 Korea Research Insitute Of Chemical Technology HIV reverse transcriptase inhibitors
KR101551238B1 (ko) * 2007-06-29 2015-09-09 한국화학연구원 신규한 ｈｉｖ 역전사효소 억제제
KR20100092960A (ko) 2007-12-21 2010-08-23 한국화학연구원 Ｈｉｖ 역전사 효소 억제제의 제조 방법
SI2295414T1 (sl) * 2008-06-03 2012-12-31 Taiho Pharmaceutical Co., Ltd. Uracilna spojina, ki ima inhibitorno aktivnost za humano deoksiuridin-trifosfatazo, ali njena sol
WO2010068899A1 (en) * 2008-12-12 2010-06-17 Creighton University Nanoparticles comprising combinations of antiretroviral agents and use thereof
US8921415B2 (en) 2009-01-29 2014-12-30 Mapi Pharma Ltd. Polymorphs of darunavir
EP2399910B1 (en) 2009-02-13 2014-04-02 Shionogi&Co., Ltd. Triazine derivatives as p2x3 and/or p2x2/3 receptor antagonists and pharmaceutical composition containing them
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
JP5406934B2 (ja) * 2009-06-22 2014-02-05 エムキュア ファーマシューティカルズ リミテッド ジアリールピリミジン非ヌクレオシド系逆転写酵素阻害剤の合成方法
GB0913636D0 (en) * 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
ES2516916T3 (es) 2010-01-28 2014-10-31 Mapi Pharma Limited Procedimiento para la preparación de darunavir e intermedios de darunavir
US20110293585A1 (en) 2010-04-21 2011-12-01 Helix Therapeutics, Inc. Compositions and methods for treatment of lysosomal storage disorders
US20110262406A1 (en) 2010-04-21 2011-10-27 Yale University Compositions and methods for targeted inactivation of hiv cell surface receptors
EP2604260B1 (en) * 2010-08-10 2017-05-10 Shionogi&Co., Ltd. Novel heterocyclic derivatives and pharmaceutical composition containing same
JP5594706B2 (ja) 2010-08-10 2014-09-24 塩野義製薬株式会社 トリアジン誘導体およびそれを含有する鎮痛作用を有する医薬組成物
MY158809A (en) * 2010-09-22 2016-11-15 Craun Res Sdn Bhd Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same
EP2640705A2 (en) 2010-11-15 2013-09-25 Katholieke Universiteit Leuven Novel antiviral compounds
ES2746859T3 (es) * 2014-04-11 2020-03-09 Gilead Sciences Inc Métodos para la preparación de análogos de nucleótidos antivirales
ES3018133T3 (en) 2011-11-30 2025-05-14 Univ Emory Jak inhibitors for use in the prevention or treatment of a viral disease caused by a coronaviridae
CA2863632C (en) 2012-01-19 2017-07-11 The Johns Hopkins University Nanoparticle formulations with enhanced mucosal penetration
JP6124351B2 (ja) 2012-02-09 2017-05-10 塩野義製薬株式会社 複素環および炭素環誘導体
EP2941423B1 (en) 2013-01-07 2021-06-09 University of Southern California Deoxyuridine triphosphatase inhibitors
WO2014124006A1 (en) 2013-02-05 2014-08-14 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
TWI637949B (zh) 2013-06-14 2018-10-11 塩野義製藥股份有限公司 胺基三衍生物及含有其等之醫藥組合物
EP3089964B1 (en) 2014-01-03 2021-02-24 University Of Southern California Heteroatom-containing deoxyuridine triphosphatase inhibitors
WO2015127389A1 (en) 2014-02-23 2015-08-27 The Johns Hopkins University Hypotonic enema formulations and methods of use
EP3939985B1 (en) 2014-12-26 2024-05-08 Emory University Pharmaceutical compositions comprising n4-hydroxycytidine derivatives for the treatment or prevention of influenza or coronavirus infections
KR20240126072A (ko) 2015-01-27 2024-08-20 더 존스 홉킨스 유니버시티 점막표면에서 활성제의 향상된 수송을 위한 저장성 하이드로겔 제제
WO2017006270A1 (en) 2015-07-08 2017-01-12 University Of Southern California Deoxyuridine triphosphatase inhibitors
WO2017006271A1 (en) 2015-07-08 2017-01-12 University Of Southern California Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
EP3319939B1 (en) 2015-07-08 2024-11-27 CV6 Therapeutics (NI) Limited Hydantoin containing deoxyuridine triphosphatase inhibitors
WO2017006283A1 (en) 2015-07-08 2017-01-12 Cv6 Therapeutics (Ni) Limited Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
US11014924B2 (en) 2016-11-23 2021-05-25 Cv6 Therapeutics (Ni) Limited Hydantoin containing deoxyuridine triphosphatase inhibitors
WO2018098204A1 (en) 2016-11-23 2018-05-31 Cv6 Therapeutics (Ni) Limited 6-membered uracil isosteres
US10858344B2 (en) 2016-11-23 2020-12-08 Cv6 Therapeutics (Ni) Limited Hydantoin containing deoxyuridine triphosphatase inhibitors
US11168059B2 (en) 2016-11-23 2021-11-09 Cv6 Therapeutics (Ni) Limited Amino sulfonyl compounds
US10829457B2 (en) 2016-11-23 2020-11-10 Cv6 Therapeutics (Ni) Limited Nitrogen ring linked deoxyuridine triphosphatase inhibitors
US11247984B2 (en) 2017-01-05 2022-02-15 Cv6 Therapeutics (Ni) Limited Uracil containing compounds
US12156523B2 (en) * 2017-03-17 2024-12-03 Mmag Co., Ltd. Plant disease control agent
ES2995458T3 (en) 2017-12-07 2025-02-10 Univ Emory N4-hydroxycytidine derivative and anti-viral uses related thereto
US12496279B2 (en) 2019-04-11 2025-12-16 The Johns Hopkins University Nanoparticles for drug delivery to brain
CN115536596A (zh) * 2022-11-08 2022-12-30 巨鑫生物制药股份有限公司 一种acc007中间体的制备方法
CN117209435A (zh) * 2023-08-04 2023-12-12 浙江海昇药业股份有限公司 一种微通道制备2,6-二甲氧基-4-氨基嘧啶的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000051990A1 (en) * 1999-03-04 2000-09-08 Korea Research Institute Of Chemical Technology Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
WO2000061564A1 (en) * 1999-04-10 2000-10-19 Samjin Pharmaceutical Co., Ltd. Antiviral pyrimidinedione derivatives and process for the preparation thereof

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656209A (en) * 1982-05-26 1987-04-07 Ciba-Geigy Corporation Chlorinated thermoplastics stabilized with aminouracils
KR0155168B1 (ko) * 1989-09-29 1998-11-16 미우라 아끼라 6-치환된 아시클로피리미딘 뉴클레오시드 유도체 및 이를 활성성분으로 함유하는 항비루스제
DE69129998T2 (de) * 1990-02-15 1998-12-24 Takeda Chemical Industries, Ltd., Osaka Pyrimidindionderivate, deren Herstellung und Verwendung
IL99731A0 (en) * 1990-10-18 1992-08-18 Merck & Co Inc Hydroxylated pyridine derivatives,their preparation and pharmaceutical compositions containing them
DE69430587T2 (de) * 1994-02-28 2003-01-09 Sunkyong Industries Co. Ltd., Suwon Pyrimidin-acyclonukleosid-derivate
JPH083143A (ja) 1994-06-21 1996-01-09 Mitsubishi Chem Corp ６−アラルキル置換ピリミジン誘導体の製造方法
US6174998B1 (en) * 1996-03-12 2001-01-16 Roche Diagnostics Gmbh C-nucleoside derivatives and their use in the detection of nucleic acids
WO1997030979A1 (en) * 1996-02-22 1997-08-28 Samjin Pharmaceutical Co., Ltd. New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients
KR100219922B1 (ko) * 1996-05-16 1999-09-01 이서봉 신규한 항바이러스성 6-아릴옥시 및 6-아릴카르보닐 2,4-피리미딘디온 유도체 및 그의 제조 방법
JPH10130245A (ja) 1996-09-06 1998-05-19 Mitsubishi Chem Corp アシクロヌクレオシドの製造方法
JPH10130244A (ja) 1996-09-06 1998-05-19 Mitsubishi Chem Corp アシクロヌクレオシドの製造方法
WO1998014436A1 (en) 1996-10-02 1998-04-09 Dupont Pharmaceuticals Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same
JPH10168068A (ja) 1996-12-05 1998-06-23 Mitsubishi Chem Corp アシクロヌクレオシドの製造方法
US5998411A (en) * 1998-03-17 1999-12-07 Hughes Institute Heterocyclic nonnucleoside inhibitors of reverse transcriptase
JP2002509922A (ja) * 1998-03-27 2002-04-02 デュポン ファーマシューティカルズ カンパニー ４，４−二置換−３，４−ジヒドロ−２（１ｈ）−キナゾリンチオン誘導体、それらの調製法、およびｈｉｖ逆転写酵素阻害剤としてのそれらの使用
FR2779721A1 (fr) 1998-06-15 1999-12-17 Expansia Sa Substitution d'une 1,5-dialkyl uracile en position 6
FR2779722A1 (fr) 1998-06-15 1999-12-17 Expansia Sa Hydrogenation de 6-alpha-alkylcarboxy methylaryl-1,5-dialkyl uracile
WO2001023363A1 (en) 1999-09-29 2001-04-05 Sankyo Company, Limited Sulfonamide derivatives
JP2001114767A (ja) 1999-10-15 2001-04-24 Sumika Fine Chemicals Co Ltd ピリミジン化合物の製造方法、およびその中間体の製造方法
US6995283B2 (en) * 2001-03-02 2006-02-07 Smithkline Beecham Corporation Benzophenones as inhibitors of reverse transcriptase
JP2002284686A (ja) 2001-03-28 2002-10-03 Sankyo Co Ltd スルホンアミド化合物を含有する医薬組成物
WO2003029226A1 (en) 2001-09-26 2003-04-10 Basf Aktiengesellschaft Heterocyclyl substituted phenoxyalkyl-, phenylthioalkyl-, phenylaminoalkyl- and phenylalkyl-sulfamoylcarboxamides
WO2003057677A1 (en) 2002-01-11 2003-07-17 Syddansk Universitet Anti-retroviral 5,6-disubstituted acyclopyrimidine nucleoside derivatives
ES2276075T3 (es) 2002-01-31 2007-06-16 Ciba Specialty Chemicals Holding Inc. Estabilizacion de poliolefina en contacto permanente con agua clorada.
WO2004030611A2 (en) * 2002-08-23 2004-04-15 Ribapharm Inc. Non-nucleoside reverse transcriptase inhibitors
WO2006070292A2 (en) 2004-10-12 2006-07-06 Queen's University At Kingston Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
US7250421B2 (en) * 2005-01-31 2007-07-31 University Of Georgia Research Foundation, Inc. Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase
US20060223834A1 (en) * 2005-04-04 2006-10-05 Vasu Nair Diketo acids on nucleobase scaffolds as inhibitors of Flaviviridae
CN101405002A (zh) * 2005-12-29 2009-04-08 詹森药业有限公司 激肽原2受体拮抗剂
CN101495464B (zh) * 2005-12-29 2014-03-05 詹森药业有限公司 激肽原1受体拮抗剂
WO2007106450A2 (en) 2006-03-10 2007-09-20 University Of Georgia Research Foundation, Inc. Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase in combination therapy
SG174016A1 (en) * 2006-07-24 2011-09-29 Korea Res Inst Chem Tech Hiv reverse transcriptase inhibitors
KR101551238B1 (ko) * 2007-06-29 2015-09-09 한국화학연구원 신규한 ｈｉｖ 역전사효소 억제제

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000051990A1 (en) * 1999-03-04 2000-09-08 Korea Research Institute Of Chemical Technology Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
WO2000061564A1 (en) * 1999-04-10 2000-10-19 Samjin Pharmaceutical Co., Ltd. Antiviral pyrimidinedione derivatives and process for the preparation thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JI, LEI ET AL.: CHEM. PHARM. BULL., vol. 54, no. 9, 2006, pages 1248-1253, XP002494625 *

Also Published As

Publication number Publication date
KR20090040449A (ko) 2009-04-24
CA2658479A1 (en) 2008-02-07
US8106064B2 (en) 2012-01-31
IL196675A0 (en) 2009-11-18
KR20110089463A (ko) 2011-08-08
CN101495461A (zh) 2009-07-29
WO2008016522A2 (en) 2008-02-07
US20080070920A1 (en) 2008-03-20
JP2009544710A (ja) 2009-12-17
NO20090835L (no) 2009-04-23
HRP20090114A2 (hr) 2010-03-31
BRPI0714880A2 (pt) 2013-05-21
NZ573793A (en) 2012-01-12
US20100034827A1 (en) 2010-02-11
EA200900213A1 (ru) 2009-06-30
MX2009000871A (es) 2009-05-08
WO2008016522A3 (en) 2008-12-11
SG174016A1 (en) 2011-09-29
AU2007281604A1 (en) 2008-02-07
AP2009004759A0 (en) 2009-02-28
EP2044037A2 (en) 2009-04-08
UA95955C2 (ru) 2011-09-26

Similar Documents

Publication Publication Date Title
AP2514A (en) HIV reverse transcriptase inhibitors
ZA201000023B (en) Novel hiv reverse transcriptase inhibitors
IL188615A0 (en) Hiv reverse transcriptase inhibitors
IL199103A0 (en) Non-nucleoside reverse transcriptase inhibitors
EP2220091A4 (en) REVERSE transcriptase inhibitors
IL196655A0 (en) Non-nucleoside reverse transcriptase inhibitors
IL205386A0 (en) Non - nucleoside reverse transcriptase inhibitors
IL200748A0 (en) Non-nucleoside reverse transcriptse inhibitors
IL197777A0 (en) Enantiomerically pure phosphoindoles as hiv inhibitors
IL194434A0 (en) Hcv/hiv inhibitors and their uses
EP2076492A4 (en) NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS
SI2094702T1 (sl) Virusni inhibitorji
EP2099789A4 (en) INHIBITORS OF HIV REPLICATION
ZA201101975B (en) Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
TWI372619B (en) Non-nucleoside reverse transcriptase inhibitors
IL180495A0 (en) Benzyltriazolone compounds as nin-nucleoside reverse transcriptase inhibitors
IL202143A0 (en) Non-nucleoside reverse transcriptase inhibitors
IL200886A0 (en) Non-nucleoside reverse transcriptase inhibitors
EP2134336A4 (en) HIV PROTEASE INHIBITORS DERIVED FROM BENZOFURAN
ZA200900071B (en) Non-nucleoside reverse transcriptase inhibitors
EP1756091A4 (en) NON-NUCLEOSIDE INHIBITORS OF REVERSE TRANSCRIPTASE
ZA200800185B (en) Hiv reverse transcriptase inhibitors
ZA200902172B (en) Enantiomerically pure phosphoindoles as HIV inhibitors
ZA200805373B (en) Avian telomerase reverse transcriptase
ZA200708752B (en) Component